Phase 3 Chronic Subdural Hematoma Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.
Chronic Subdural Hematomas
University of Rostock164 enrolled1 locationNCT07556991
Recruiting
Phase 2Phase 3
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)
Chronic Subdural Hematoma
St. Olavs Hospital274 enrolled1 locationNCT07245264